Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

TZT-1027 exhibits promising preclinical profile

July 23, 1997

Warner-Lambert describes compounds that modulate signal transduction pathways

July 23, 1997

Bristol-Myers Squibb and GBF to discover lead anticancer compounds

July 22, 1997

DepoTech issued U.S. patents covering DepoFoam technology

July 22, 1997

TAP receives FDA approval to market new formulation of Lupron Depot

July 21, 1997

Syncor to distribute two radiopharmaceuticals from DuPont Merck

July 21, 1997

Genzyme Molecular Oncology and NCI enter drug discovery collaboration

July 21, 1997

GHRH antagonist active in vivo against human renal adenoarcinoma

July 21, 1997

Lung cancer survival improved with new radiotherapy technique

July 21, 1997

Medeva acquires license to anthracycline derivative for the treatment of bladder cancer

July 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...